Marshall Wace North America’s Calithera Biosciences, Inc CALA Stock Holding History

Marshall Wace North America’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$670K	Buy	+15,362	New	+$663K	﹤0.01%	1046
2021 Q2	–	Sell	-1,245	Closed	-$60K	–	1929
2021 Q1	$60K	Sell	1,245 -12,086	-91%	-$703K	﹤0.01%	1451
2020 Q4	$1.31M	Sell	13,331 -21,221	-61%	-$1.86M	0.01%	875
2020 Q3	$2.38M	Sell	34,552 -33,634	-49%	-$2.93M	0.02%	539
2020 Q2	$7.2M	Buy	68,186 +38,379	+129%	+$4.56M	0.05%	312
2020 Q1	$2.65M	Buy	+29,807	New	+$3.55M	0.02%	433
2018 Q2	–	Sell	-657	Closed	-$83K	–	1818
2018 Q1	$83K	Buy	+657	New	+$102K	﹤0.01%	1373
2017 Q4	–	Sell	-579	Closed	-$185K	–	1690
2017 Q3	$185K	Buy	+579	New	+$183K	﹤0.01%	1184

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace North America's CALA Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Calithera Biosciences, Inc (CALA) in Q3 2021: 15,362 shares worth $670K. The stake represents ﹤0.01% of the portfolio and ranks #1046 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in CALA as recently as Q1 2021.

Marshall Wace North America first reported a position in CALA in Q3 2017 and has held it in 8 quarters since. The position peaked at $7.2M in Q2 2020. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

Marshall Wace North America held 15,362 shares of Calithera Biosciences, Inc worth $670K as of Q3 2021.
Calithera Biosciences, Inc was a new Marshall Wace North America position in Q3 2021.
Calithera Biosciences, Inc made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1046 holding.
Marshall Wace North America first reported a position in Calithera Biosciences, Inc in Q3 2017 and has held it in 8 quarters since.
Marshall Wace North America's Calithera Biosciences, Inc position peaked at $7.2M in Q2 2020.
66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.